Postprandial Responses to Typical UK Meal Nutrient Profiles
Pre-PREDICT
1 other identifier
interventional
17
1 country
1
Brief Summary
The aim of the current study is to investigate the postprandial metabolic response to typically consumed fat and carbohydrate doses in single meals. An additional aim is to validate the use of dry blood spot (DBS) for triglyceride analysis versus venous blood sampling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 24, 2018
CompletedFirst Posted
Study publicly available on registry
May 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFebruary 18, 2020
April 1, 2018
5 months
April 24, 2018
February 17, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Postprandial lipaemia
Change in serum triglycerides
0-4 hours postprandially
Secondary Outcomes (1)
Postprandial glycaemia
0-4 hours postprandially
Other Outcomes (2)
Postprandial plasma insulin
0-4 hours postprandially
Postprandial plasma c-peptide
0-4 hours postprandially
Study Arms (2)
High fat meal
EXPERIMENTALMuffin containing 30g fat
Medium fat meal
EXPERIMENTALMuffin containing 20g fat
Interventions
Eligibility Criteria
You may qualify if:
- Males and females aged 18-65 years.
You may not qualify if:
- Able to understand the information sheet and willing to comply with study protocol.
- Able to give informed consent.
- Refuse or are unable to give informed consent to participate in the study
- BMI \>32 kg/m2
- BP \>170/100 mm Hg
- Have had long term inflammatory disease or cancer in the last three years.
- Have had long term gastrointestinal disorders including inflammatory bowel disease (IBD) or Coeliac disease (gluten allergy).
- Are taking the following daily medications: immunosuppressants, antibiotics in the last three months
- Are long-term users of PPIs, unless they are able to stop two weeks before the start of the study.
- Have type I diabetes mellitus or type II diabetes mellitus.
- Are currently suffering from acute clinically diagnosed depression.
- Have had a heart attack (myocardial infarction) or stroke in the last 6 months.
- Are pregnant
- Are vegan, suffering from an eating disorder or unwilling to take foods that are part of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King's College London
London, UK, SE1 9NH, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Berry, PhD
King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2018
First Posted
May 21, 2018
Study Start
April 1, 2018
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
February 18, 2020
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share